ARKG vs. PTH ETF Comparison

Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to Invesco DWA Healthcare Momentum ETF (PTH)
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$89.32

Average Daily Volume

5,087,274

Number of Holdings *

47

* may have additional holdings in another (foreign) market
PTH

Invesco DWA Healthcare Momentum ETF

PTH Description The PowerShares Dynamic Healthcare Sector Portfolio (Fund) is based on the Dynamic Healthcare Sector IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index thoroughly evaluates companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 60 US health care companies. These are companies that are principally engaged in the business of providing health care-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$152.21

Average Daily Volume

73,284

Number of Holdings *

52

* may have additional holdings in another (foreign) market
Performance
ARKG PTH
30 Days -2.70% -7.61%
60 Days -20.26% -19.13%
90 Days -15.42% -11.89%
12 Months 166.39% 70.49%
1 Overlapping Holdings
Grade Symbol Weight in ARKG Weight in PTH Overlap
B TXG 1.59% 2.56% 1.59%
ARKG Overweight 46 Positions Relative to PTH
Grade Symbol Weight
F TDOC 7.97%
D TWST 5.61%
D PACB 5.4%
D EXAS 3.98%
C REGN 3.82%
D CDNA 3.68%
D CRSP 3.53%
D VRTX 3.44%
F TAK 3.14%
D FATE 3.12%
F IOVA 3.06%
F NVS 3.05%
F NVTA 2.82%
F ARCT 2.63%
F INCY 2.45%
F PSNL 2.39%
F IONS 2.06%
C ACCD 1.94%
D PSTG 1.86%
D CSTL 1.58%
D BEAM 1.58%
F BLI 1.55%
B BMY 1.53%
D VEEV 1.53%
F CLLS 1.52%
D SDGR 1.5%
B TMO 1.47%
A GOOGL 1.37%
F SRPT 1.35%
C NTLA 1.26%
B CDXS 1.18%
D VCYT 1.13%
F EDIT 1.03%
D PHR 1.02%
F ADPT 1.02%
B GH 1.0%
C NSTG 0.85%
D AQB 0.79%
F MCRB 0.78%
F CERS 0.5%
C RPTX 0.39%
F SURF 0.36%
F LGVW.U 0.33%
F SYRS 0.32%
D ONEM 0.13%
F ONVO 0.04%
ARKG Underweight 51 Positions Relative to PTH
Grade Symbol Weight
D BNGO -4.53%
B HZNP -4.3%
D FLGT -3.98%
C IDXX -3.68%
C SEEL -3.33%
C ACRS -3.26%
C CRIS -2.8%
A CRL -2.49%
B VCEL -2.47%
B ALGN -2.4%
D CTLT -2.4%
D AVXL -2.38%
B OMI -2.3%
D BCRX -2.26%
B MTD -2.26%
A MEDP -2.11%
B A -2.03%
D NVAX -1.84%
C CYH -1.79%
B ENSG -1.79%
F VERU -1.74%
B ACHC -1.72%
B ATRC -1.6%
D THC -1.57%
D ITCI -1.57%
D XLRN -1.56%
B OMCL -1.55%
A TECH -1.53%
B AXNX -1.44%
B NARI -1.39%
D CDXC -1.36%
A BRKR -1.34%
D MD -1.3%
D MYGN -1.28%
D GKOS -1.28%
C SEM -1.26%
C SGRY -1.26%
B PDCO -1.22%
D TMDX -1.2%
B ORGO -1.16%
D TVTY -1.13%
D ONCT -1.08%
B BKD -1.04%
C ATEC -1.01%
C EOLS -0.98%
D CLDX -0.96%
B INOV -0.95%
C EVH -0.93%
D HSKA -0.89%
C PRTA -0.87%
F SRRK -0.52%
Compare ETFs